Spinocerebellar ataxia type 42

Get in touch with RARE Concierge.

Contact RARE Concierge

Synonyms: SCA42

A rare autosomal dominant cerebellar ataxia characterized by pure and slowly progressive cerebellar signs combining gait instability dysarthria nystagmus saccadic eye movements and diplopia. Less frequent clinical signs and symptoms include spasticity hyperreflexia decreased distal vibration sense urinary urgency or incontinence and postural tremor.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview. Reference: Access aggregated data from Orphanet at Orphadata. Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http://www.orphadata.org. Data version February 2026

Newly diagnosed with
Spinocerebellar ataxia type 42?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

Childhood Dementia Initiative

Our vision is for sustainable global health solutions for childhood dementia. This will be achieved through the following outcomes: - Treatments and cures available for children with dementia - Access to equitable and quality care for children with dementia and their families - Childhood dementia is a global health policy priority.

Genetic Support Network of Victoria

The Genetic Support Network of Victoria is an organisation that supports people living with genetic, undiagnosed and rare conditions and those who support them including community and families, patient support organisations, health professionals and industry. Our vision is our community flourishing and living their best lives.

Project CASK

VISION Project CASK believes in a world free of the life limitations and debilitating effects of CASK gene disorders. ​MISSION To accelerate breakthroughs in research to develop treatments and a cure for CASK gene disorders. ​VALUES Collaboration. Transparency. Urgency.

TNPO2 Foundation

Develop personalized therapeutics for ultra rare genetic neurodevelopmental diseases, especially those arising from mutations in the TNPO2 gene.

Location: State State

Don't see your organization here. Let us know here.

Clinical Trials

For a list of clinical trials in this disease area, please click here.